<DOC>
	<DOCNO>NCT01302080</DOCNO>
	<brief_summary>To evaluate long-term impact treatment sertraline aspect cognitive , emotional physical development pubertal maturation pediatric subject age 6 16 year ( inclusive ) diagnosis anxiety disorder , depressive disorder obsessive compulsive disorder .</brief_summary>
	<brief_title>Sertraline Pediatric Registry Evaluation Safety ( SPRITES )</brief_title>
	<detailed_description>Purposive sample : patient randomly select , , must meet certain inclusion criterion order qualify potential study participant .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Children age 6 16 ( inclusive ) anxiety , depression , obsessivecompulsive disorder , receive treatment outpatient setting , prescribe new prescription sertraline treat one studyqualifying disorder begin psychotherapy . Psychotic study entry Diagnosis bipolar disorder Diagnosis schizoaffective schizophrenia Anorexia Bulimia eat disorder otherwise specify ( NOS ) Autism Pervasive developmental disorder High risk suicide within 2 week initiate study treatment Significant mental retardation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>prospective</keyword>
	<keyword>cohort</keyword>
	<keyword>sertraline</keyword>
	<keyword>long-term impact</keyword>
	<keyword>cognition</keyword>
	<keyword>emotional physical development</keyword>
	<keyword>pubertal maturation</keyword>
</DOC>